IRIS
CUCINOTTA, MARIAPAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.971
NA - Nord America 1.462
AS - Asia 792
SA - Sud America 287
AF - Africa 25
OC - Oceania 2
Totale 7.539
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.842
US - Stati Uniti d'America 1.438
SG - Singapore 278
CN - Cina 260
IE - Irlanda 257
NL - Olanda 252
BR - Brasile 250
SE - Svezia 214
DE - Germania 113
HK - Hong Kong 85
FI - Finlandia 66
GB - Regno Unito 56
IN - India 51
VN - Vietnam 45
RU - Federazione Russa 35
PL - Polonia 34
FR - Francia 27
CA - Canada 13
UA - Ucraina 13
CZ - Repubblica Ceca 12
TR - Turchia 11
AR - Argentina 10
CH - Svizzera 10
IR - Iran 10
BE - Belgio 9
IQ - Iraq 9
CI - Costa d'Avorio 7
CO - Colombia 7
ES - Italia 7
MX - Messico 7
ZA - Sudafrica 7
EC - Ecuador 6
BD - Bangladesh 5
AL - Albania 4
AZ - Azerbaigian 4
JP - Giappone 4
LT - Lituania 4
PK - Pakistan 4
PY - Paraguay 4
SA - Arabia Saudita 4
UY - Uruguay 4
UZ - Uzbekistan 4
ID - Indonesia 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
NP - Nepal 3
RO - Romania 3
AT - Austria 2
BY - Bielorussia 2
CL - Cile 2
DK - Danimarca 2
IL - Israele 2
JM - Giamaica 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
KG - Kirghizistan 1
KI - Kiribati 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 7.539
Salva come PNG Salva come JPEG
Città #
Milan 399
Rome 337
Dublin 256
Dallas 240
Chandler 215
Ashburn 192
Naples 164
Singapore 148
Nyköping 136
Beijing 123
Hong Kong 84
Turin 83
Bari 70
Munich 70
Bologna 66
Palermo 56
Florence 54
The Dalles 53
Jacksonville 51
Catania 48
Dearborn 48
Genoa 48
New York 41
Los Angeles 35
Cambridge 34
Princeton 34
Medford 32
Warsaw 32
Des Moines 30
Messina 27
Trieste 27
Modena 25
Cagliari 24
Hyderabad 24
Brescia 23
Turku 22
Ann Arbor 21
Lancaster 21
Jinan 20
Verona 20
Pisa 18
Padova 17
Parma 17
São Paulo 17
Bergamo 16
Buffalo 16
Pune 15
Nanjing 14
Houston 13
Hanoi 12
Ho Chi Minh City 12
Novara 12
Pescara 12
Prato 12
Boardman 11
Bremen 11
Cosenza 11
Monza 11
San Mateo 11
Cascina 10
Modugno 10
Moscow 10
Reggio Emilia 10
Venice 10
Brussels 9
Padua 9
Sassari 9
Shenyang 9
Ancona 8
Helsinki 8
Ningbo 8
Perugia 8
Redondo Beach 8
Rio de Janeiro 8
Taranto 8
Udine 8
Abidjan 7
Brasília 7
Eboli 7
Hebei 7
Johannesburg 7
Livorno 7
Lucca 7
Montreal 7
Oristano 7
Vicenza 7
Wilmington 7
Aversa 6
Brno 6
Brooklyn 6
Capaccio 6
Casoria 6
Catanzaro 6
Cepagatti 6
Denver 6
Ferrara 6
Fisciano 6
Gragnano 6
Guarulhos 6
London 6
Totale 3.996
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.195
Oxidative Stress: Harms and Benefits for Human Health 140
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 139
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 138
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 136
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 136
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 126
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 125
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 124
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 119
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 115
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 112
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 112
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 106
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 105
Hyperthyroidism treatment with calculated activity of 131–radioiodine 105
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 102
High grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 93
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 92
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 91
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 91
High-grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 90
Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gαs genes in a mild to moderate iodine-deficient Caucasian population 90
Middle-Term Outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 86
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 86
Middle-term outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 82
IMPIEGO DEL 99mTC-MIBI PER VALUTARE IL RISCHIO DI MALIGNITA’ DEL NODULO TIROIDEO 81
VANTAGGI DELLA DOSIMETRIA PERSONALIZZATA VS ATTIVITA’ STANDARD DI RADIOIODIO NELLA TERAPIA DELL’IPERTIROIDISMO: LA NOSTRA ESPERIENZA 77
Is pre-treatment SUVmax an useful indicator of survival in patients with advanced non-small-cell lung cancer? 76
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 76
Two-year survival prediction in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantification 75
Stage III-IV non small cell lung cancer: the impact of SUVmax and %SUVmax in predicting survival after chemotherapy 68
Gliomas with intratumoral abscess formation: Description of new cases, review of the literature, and the role of (99m)TC-Leukoscan 64
RADIOIODINE UPTAKE IN ABDOMINAL DERMOID CYST IN A PATIENT WITH DIFFERENTIATED THYROID CANCER (DTC) 57
null 42
null 27
Totale 7.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.248
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 9 5 3 18 12 22 6
2021/2022249 1 30 1 8 15 1 29 8 1 49 30 76
2022/2023787 62 107 36 63 47 59 21 40 307 15 22 8
2023/20241.374 22 50 72 73 70 134 103 123 96 202 178 251
2024/20253.215 216 141 234 328 268 198 229 459 390 244 234 274
2025/20261.368 240 252 303 259 276 38 0 0 0 0 0 0
Totale 7.579